RxDoctor Payments Data

John Tieman, MD

Dermatology · New Braunfels, TXNPI 1114089844

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.4% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $939, more than ten times the $11 reported in 2019. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.

$2,022in general payments, 2019–2025

Across 83 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$270
  • E.r. Squibb & Sons, L.L.C.$251
  • Novartis$246
  • Galderma Laboratories, L.p.$212
  • UCB, Inc.$167
  • AbbVie$166
  • plus $709 from 7 others

What the payments were for

  • Food & beverage$1,82790%
  • Education$19510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,022 in reported general payments places this provider in the 35th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024
$249,391
Medicare patients
808
Services billed
6,777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab11$76,018
Clobetasol Propionate38$1,830
Metronidazole33$1,525
Desonide22$1,426
Ketoconazole88$1,242
Mometasone Furoate54$941
Clindamycin Phosphate17$549
Triamcinolone Acetonide68$506
CefuroximeCefuroxime Axetil25$473
Doxycycline Hyclate34$394
MethotrexateMethotrexate Sodium16$370
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc28$351
Imiquimod12$346
Levocetirizine Dihydrochloride14$333
Mupirocin39$304

Paid to pharmacies, not to this prescriber.

Other dermatology in New Braunfels

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →